Tumor-Infiltrating Lymphocytes for Prognostic Stratification in Nonmetastatic Colon Cancer—Are We There Yet?
Author:
Affiliation:
1. Department of Oncology, Mayo Clinic, Mayo Comprehensive Cancer Center, Rochester, Minnesota
2. Department of Pathology and Laboratory Medicine, Mayo Clinic, Mayo Comprehensive Cancer Center, Rochester, Minnesota
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Link
https://jamanetwork.com/journals/jamaoncology/articlepdf/2778091/jamaoncology_sinicrope_2021_vp_210003_1626360237.18215.pdf
Reference9 articles.
1. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.;Pagès;Lancet,2018
2. The prognostic implications of tumor infiltrating lymphocytes in colorectal cancer: a systematic review and meta-analysis.;Idos;Sci Rep,2020
3. Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study.;Pagès;Ann Oncol,2020
4. Contribution of Immunoscore and molecular features to survival prediction in stage III colon cancer.;Sinicrope;JNCI Cancer Spectr,2020
5. Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.;Denkert;Mod Pathol,2016
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRC;Clinical Cancer Research;2024-02-29
2. Spatio-temporal heterogeneity in cancer evolution and tumor microenvironment of renal cell carcinoma with tumor thrombus;Cancer Letters;2023-09
3. RGCC is a Prognostic Biomarker and Correlates with Immune Infiltrates in Breast Cancer;2023-05-30
4. PLK1 is a prognostic marker that inhibits immune infiltration in lung adenocarcinoma through necroptosis;2023-02-28
5. Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer;Nature Medicine;2023-01-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3